This is a snippet of the transcript, sign up to read more.
Good question. They entered the public casualty space about six years ago. They've been very aggressive, at least for them. Everyone in the space that I used to talk to, including the brokers, honestly, we all felt it was coming. You know, the tail is coming. But they play in the lead layer. They initially put up a limit of 10 million directly above the pool retention and took the whole 10 million. Now, they've cut back to five million. They write a ton of business in California. We would know what the expiring premium was. Although I wasn't quoting that layer, we'd see what they quoted it at in a market where you should be getting rate increases, and you'd say to yourself, what are they doing?
This is a snippet of the transcript, sign up to read more.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2024 IP 1 Ltd. All rights reserved.
Subscribe to access hundreds of interviews and primary research